AGROAMERICA
23.5.2024 19:59:35 CEST | Business Wire | Press release
This year marks a significant milestone for AgroAmerica, a family-owned, vertically integrated company that provides sustainable food and ingredients globally. AgroAmerica proudly launches PlanetA, an ambitious new sustainability strategy aimed at driving tangible change and redefining the paradigms of sustainable food systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523124865/en/
PlanetA - Sustainability Strategy (Photo: Business Wire)
PlanetA emerges from the fusion of AgroAmerica's essence with a profound focus on the planet, underscoring the company's strong commitment to sustainable practices. It embodies the idea that Earth is our only home and everyone’s responsibility, highlighting AgroAmerica's action plan to nurture the planet: our shared home.
Under the visionary leadership of AgroAmerica's CEO, Fernando Bolaños, the company embarks on a transformative journey with PlanetA. This comprehensive strategy addresses key material issues through specific, time-bound objectives. Mr. Bolaños asserts, "We are determined to make a tangible difference and set new standards for what a sustainable food system truly entails."
Recognizing that growth and profitability are crucial pillars of success, AgroAmerica endorses a perspective transcending mere financial gain. "We firmly believe that true success lies in integrating economic growth with environmental management and social responsibility. We aim to surpass neutrality and achieve Net Positivity – where our actions not only mitigate but actively contribute to a thriving planet," stated Javier Aguirre, AgroAmerica's Chief Sustainability Officer.
AgroAmerica emerges as one of the leaders in the region by committing to a Net Zero target. Aligned with science-based reduction targets outlined by the SBT initiative, the company is determined to reduce corporate carbon emissions and foster a more sustainable future.
In a pioneering pilot model, AgroAmerica is spearheading the adoption of regenerative agriculture practices across its operations. Through close collaboration with global NGOs and academia, they are developing a production model that champions environmental regeneration while ensuring agricultural productivity.
Through PlanetA, AgroAmerica reaffirms its dedication to leading sustainability within the food industry. In today's evolving market landscape, characterized by heightened complexities and demands, the imperative for transparency, forward-looking strategies, accountability, and trust has never been more pronounced. In light of these challenges, PlanetA embodies AgroAmerica's pledge to position itself as a leader in responsible business practices, fostering the well-being of our planet, our shared home.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240523124865/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom